课题基金 / 基金详情

ORAL TOLVAPTAN TABLETS IN SUBJECTS HOSPITALIZED WITH WORSENING CHF

ORAL TOLVAPTAN TABLETS IN SUBJECTS HOSPITALIZED WITH WORSENING CHF
因心力衰竭恶化住院的患者口服托伐普坦片
批准号:
7377518
负责人:
KIRKWOOD F ADAMS
金额:
$0.02万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

KIRKWOOD F ADAMS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The reason for this study is to find out the potential benefits and safety of tolvaptam.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
3/3-Multi-Site - Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
3/3-Multi-Site - Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
CLINICAL TRIAL: A CONGESTIVE HEART FAILURE TRIAL INVESTIGATING OUTCOMES OF EXERC
A CONGESTIVE HEART FAILURE TRIAL INVESTIGATING OUTCOMES OF EXERCISE TRAINING
海外基金